Quest Diagnostics Reports First Quarter 2022 Financial Results; Raises Guidance for Full Year 2022
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
CFRA Downgrades Quest Diagnostics (DGX) to Hold
April 21, 2022 1:53 PM EDTCFRA downgraded Quest Diagnostics (NYSE: DGX) from Buy to Hold with a price target of $157.00 (from $160.00).
For an analyst ratings summary and ratings history on Quest Diagnostics click here. For more ratings news on Quest Diagnostics click here.
Shares of Quest Diagnostics closed at $138.45 yesterday.
... MoreQuest Diagnostics (DGX) Tops Q1 EPS by 25c, Raises FY EPS Guidance
April 21, 2022 6:46 AM EDTQuest Diagnostics (NYSE: DGX) reported Q1 EPS of $3.22, $0.25 better than the analyst estimate of $2.97. Revenue for the quarter came in at $2.61 billion versus the consensus estimate of $2.63 billion.
GUIDANCE:
Quest Diagnostics sees FY2022 EPS of $9.00-$9.50, versus the consensus of... More
